Abstract
Aim: The aim of the present study was the establishment of a process for the extraction of phytochemicals from Ficus racemosa.
Background: Ficus racemosa is an underutilized crop containing numerous phytochemicals having the potential to play a significant role in food and nutritional security. However, it has lower consumer acceptability because of its taste and presence of fig wasps. In these situations, extraction of the phytochemical from this crop is an alternate option for its efficient utilization in any food matrices.
Objective: The objective of the present study was to optimize the extraction technique for the extraction of phytochemicals from dried Ficus racemosa powder.
Methods: Present study shows the method for extraction of phytochemicals from dried Ficus racemosa powder using different variables, i.e. solid-to-liquid ratio (1:10-1:40), temperature (30-70°C), time (30-120min) and pH (2.5-6.5).
Results: Maximum phytochemical activity was observed under optimized conditions, i.e. solid-- to-liquid ratio (1:15), temperature (59.99°C), time (30.01min.) and pH (3.50) with 0.834 desirability. The optimized extract was analyzed using HPLC-DAD, which confirms the presence of ascorbic acid, gallic acid, tannic acid, chlorogenic acid, ferulic acid, catechin, and quercetin.
Conclusion: It is concluded that Ficus racemosa can be successfully utilized for the extraction of phytochemicals.
Keywords: Ficus racemosa, extraction, phytochemical, response surface methodology, FTIR, HPLC.
The Natural Products Journal
Title:Process Optimization for Extraction of Phytochemicals from Ficus racemosa: Phytochemical Extraction
Volume: 11 Issue: 5
Author(s): Basista Rabina Sharma, Vikas Kumar*, Satish Kumar, Arashdeep Singh and Dave Jaydeep Pinakin
Affiliation:
- Department of Food Science and Technology, Punjab Agricultural University Ludhiana, Punjab, 141004,India
Keywords: Ficus racemosa, extraction, phytochemical, response surface methodology, FTIR, HPLC.
Abstract:
Aim: The aim of the present study was the establishment of a process for the extraction of phytochemicals from Ficus racemosa.
Background: Ficus racemosa is an underutilized crop containing numerous phytochemicals having the potential to play a significant role in food and nutritional security. However, it has lower consumer acceptability because of its taste and presence of fig wasps. In these situations, extraction of the phytochemical from this crop is an alternate option for its efficient utilization in any food matrices.
Objective: The objective of the present study was to optimize the extraction technique for the extraction of phytochemicals from dried Ficus racemosa powder.
Methods: Present study shows the method for extraction of phytochemicals from dried Ficus racemosa powder using different variables, i.e. solid-to-liquid ratio (1:10-1:40), temperature (30-70°C), time (30-120min) and pH (2.5-6.5).
Results: Maximum phytochemical activity was observed under optimized conditions, i.e. solid-- to-liquid ratio (1:15), temperature (59.99°C), time (30.01min.) and pH (3.50) with 0.834 desirability. The optimized extract was analyzed using HPLC-DAD, which confirms the presence of ascorbic acid, gallic acid, tannic acid, chlorogenic acid, ferulic acid, catechin, and quercetin.
Conclusion: It is concluded that Ficus racemosa can be successfully utilized for the extraction of phytochemicals.
Export Options
About this article
Cite this article as:
Sharma Rabina Basista , Kumar Vikas *, Kumar Satish , Singh Arashdeep and Pinakin Jaydeep Dave , Process Optimization for Extraction of Phytochemicals from Ficus racemosa: Phytochemical Extraction, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200728125644
DOI https://dx.doi.org/10.2174/2210315510999200728125644 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heat Shock Proteins and Ion Channels. Functional Interactions and Therapeutic Consequences
Current Pharmaceutical Biotechnology Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic
CNS & Neurological Disorders - Drug Targets On the Discovery and Development of CFTR Chloride Channel Activators
Current Pharmaceutical Design Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
Reviews on Recent Clinical Trials Editorial [Hot Topic: Glutamate Receptors and Related Processes as Drug Targets (Guest Editor: Michel Baudry)]
Current Drug Targets Stopping Drug Therapy in Epilepsy
Current Pharmaceutical Design Neurological Concepts in Ancient Greek Medicine
Current Aging Science Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications
Current Medicinal Chemistry Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Current Pharmaceutical Design Application of NMR Screening in Drug Discovery
Current Topics in Medicinal Chemistry Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms
CNS & Neurological Disorders - Drug Targets Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry How Early is Too Early? A Review of Infant Seizure Surgery Literature
Current Pediatric Reviews ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology GABA Receptors: Pharmacological Potential and Pitfalls
Current Pharmaceutical Design A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders
Current Drug Targets Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy
CNS & Neurological Disorders - Drug Targets